Medavail: Cowen says Q4 revenue view indicates upbeat prescription volumes

Medavail Holdings

17/02/2021 15:29

** Brokerage Cowen says health tech co Medavail's  MDVL.O 
Q4 rev forecast ahead of est
    ** Says results indicate prescription volumes were higher
than expected, despite second COVID-19 wave
    ** Co sees prelim Q4 rev to be in the range of $2.65 mln -
$2.85 mln  urn:newsml:reuters.com:*:nBw8FXth9a
    ** MDVL continues to execute on its expansion plan and its
value prop is resonating in the market - MDVL 
    ** Shares of MDVL up 2.3% at $14.6
    ** Up to Tuesday's close, stock fell ~3% in last 12 months

 (Reporting by Dania Nadeem in Bengaluru)
 ((Dania.Nadeem@thomsonreuters.com;))